"Designing Growth Strategies is in our DNA"

U.S. Biopharmaceuticals Market Size, Share & COVID-19 Impact Analysis, By Type (Immunomodulators {Monoclonal Antibodies, Cytokines and Others}, Enzymes {Hydrolases, Lyases and Others}, Vaccines {Recombinant Vaccines/Conjugate/Subunit, Inactivated, Live Attenuated, and Toxoid}, Hormones {Human Growth Hormones, Insulin and Others}, and Others), By Application (Cardiology, Oncology, Respiratory and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108857

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, 2022
    2. New Product Launches, By Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Regulatory Scenario
    5. Pipeline Analysis, By Key Players
    6. Impact of COVID-19 on the Market
  5. U.S. Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Bayer AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Lilly
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      12. Takeda Pharmaceutical Company Limited.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, 2022
    2. New Product Launches, By Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Regulatory Scenario
    5. Pipeline Analysis, By Key Players
    6. Impact of COVID-19 on the Market
  5. U.S. Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Bayer AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Lilly
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      12. Takeda Pharmaceutical Company Limited.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Table 01: U.S. Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2030

Table 02: U.S. Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 03: U.S. Biopharmaceuticals Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

Figure 01: U.S. Biopharmaceuticals Market Revenue Breakdown (USD billion, %) by Type, 2022 & 2030

Figure 02: U.S. Biopharmaceuticals Market Value Share (%), by Type, 2022 & 2030

Figure 03: U.S. Biopharmaceuticals Market Value Share (%), by Application, 2022 & 2030

Figure 04: U.S. Biopharmaceuticals Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 05: U.S. Biopharmaceuticals Market Share (%), By Company, 2022

U.S. Biopharmaceuticals Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports